Surmodics to Webcast Fourth Quarter 2017 Earnings Conference Call on November 8
Webcast is Live at 7:30 a.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Oct. 26, 2017--
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in
vitro diagnostic technologies to the healthcare industry, today
announced that it will host a live webcast of its fourth quarter 2017
conference call on Wednesday, November 8, at 7:30 a.m. CT (8:30 a.m.
ET). The Company will issue an earnings news release earlier that
Gary Maharaj, president and chief executive officer, and Andy LaFrence,
vice president of finance and information systems and chief financial
officer, will recap the fourth quarter 2017 financial results and
accomplishments as well as provide 2018 guidance. To access the webcast,
go to the investor relations portion of the Company’s website at www.surmodics.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 10:30 a.m. CT on
Wednesday, November 8, until 10:30 a.m. CT on Wednesday, November 15,
and can be accessed by dialing 888-203-1112 and entering conference call
ID passcode 1387738. In addition, the conference call audio and
transcript will be archived on the Company’s website following the call.
About Surmodics, Inc.
Surmodics is the global leader in surface modification technologies for
intravascular medical devices and a leading provider of chemical
components for in vitro diagnostic (IVD) tests and microarrays.
Following two recent acquisitions of Creagh Medical and NorMedix, the
Company is executing a key growth strategy for its medical device
business by expanding to offer total intravascular product solutions to
its medical device customers. The combination of proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities, enables Surmodics to significantly increase
the value it offers with highly differentiated intravascular solutions
designed and engineered to meet the most demanding requirements. With
this focus on offering total product solutions, Surmodics’ mission
remains to improve the detection and treatment of disease by using its
technology to provide solutions to difficult medical device and
diagnostic challenges. Surmodics is headquartered in Eden Prairie,
Minnesota. For more information about the company, visit www.surmodics.com.
The content of Surmodics’ website is not part of this press release or
part of any filings that the company makes with the SEC.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171026005241/en/
Source: Surmodics, Inc.
Andy LaFrence, 952-500-7000